ethacrynic sodium

Product NDC
68682-012
11-digit product format
686820012
Labeler code
68682
Product ID
68682-012_4180744c-a9ab-48e6-9b25-ea37a04add74
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ethacrynic sodium
Dosage form
POWDER, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Oceanside Pharmaceuticals
Application
NDA016093
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
1967-01-10
Marketing end
0000-00-00
Substance
ETHACRYNATE SODIUM
Active strength
50 mg/50mL
Pharmacologic classes
Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
93aead9c-5c26-5d19-73e9-d6c55a939061Product name920210525
01098bd8-4859-4cc2-9426-3489bf88d451Product name420201216

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68682-012-27ethacrynic sodium1 in 1 CARTONPOWDER, FOR SOLUTION114
68682-012-27ethacrynic sodium50 mL in 1 VIALPOWDER, FOR SOLUTION5014

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68682-012-27EA - Each68682-012238c069d-6844-4b4b-9144-baf7a37495ec12016-02-04
68682-012-50EA - Each68682-01208f74d7f-097e-4c27-83cf-3864b23973f212018-03-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ETHACRYNATE SODIUMACTIVE INGREDIENTK41MYV7MPMETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]1
ETHACRYNIC ACIDACTIVE MOIETYM5DP350VZVETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]1
MANNITOLINACTIVE INGREDIENT3OWL53L36AETHACRYNIC SODIUM POWDER, FOR SOLUTION [OCEANSIDE PHARMACEUTICALS]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68682-012ETHACRYNIC SODIUM POWDER, FOR SOLUTION ETHACRYNIC ACID TABLET [OCEANSIDE PHARMACEUTICALS]14Legacy NDC, 2 package rows20240802_f127598f-e6b3-4c35-800f-76e4217595ae.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
617325ethacrynate sodium 50 MG InjectionPSNf127598f-e6b3-4c35-800f-76e4217595ae14
1251903ethacrynic acid 25 MG Oral TabletPSNf127598f-e6b3-4c35-800f-76e4217595ae14
617325ethacrynate sodium 50 MG InjectionSCDf127598f-e6b3-4c35-800f-76e4217595ae14
1251903ethacrynic acid 25 MG Oral TabletSCDf127598f-e6b3-4c35-800f-76e4217595ae14
617325ethacrynate sodium 50 MG (equivalent to ethacrynic acid 50 MG) InjectionSYf127598f-e6b3-4c35-800f-76e4217595ae14

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68682-012-27686820012271 VIAL in 1 CARTON (68682-012-27) > 50 mL in 1 VIAL1 vial1967-01-100000-00-00NoNoCurrent
68682-012-50686820012501 VIAL in 1 CARTON (68682-012-50) > 50 mL in 1 VIAL1 vial1967-01-100000-00-00NoNoCurrent